Description
Nepafenac ophthalmic suspension, 0.3% is indicated for the treatment of pain and inflammation associated with cataract surgery. time-daily beginning 1 day prior to cataract surgery, continued on the day of surgery and through the first 2 weeks of the postoperative period.
